As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
The FDA’s new draft guidance on Bayesian methods in clinical trials has been hailed by some as a breakthrough that could speed drug development. But statisticians and researchers are divided on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results